Indrapr.Medical
Medical Care Facilities · INDRAMEDCO
Small CapHealthcareMature Stable
Shivakumar Pattabhiraman
Managing Director · Pragmatic
Company DNA
Bureaucratic
About
Indrapr.Medical is a Small Cap company in the Healthcare sector, listed on NSE as INDRAMEDCO. With a market cap of ₹4K Cr and revenue of ₹1K Cr, it is currently in the Mature Stable phase. Known for its Bureaucratic culture and Traditionalist approach to innovation, the company operates at a Steady-Marathon pace. Hospital management environment necessitating strict adherence to medical protocols, compliance, and procedural discipline. Its strategic mandate: Needs to drive operational efficiency and capacity utilization in a mature, capital-intensive hospital network.
FAQ
What kind of company is Indrapr.Medical?
Indrapr.Medical is a Small Cap Healthcare company (INDRAMEDCO) in the Mature Stable phase with a market cap of ₹4K Cr. It is classified as Bureaucratic in culture.
What is Indrapr.Medical's culture and work environment like?
Indrapr.Medical has a Bureaucratic culture with Traditionalist innovation DNA and a Steady-Marathon pace of execution. Employee brand: Steady Employer. Customer relationship style: Premium-Niche. Hospital management environment necessitating strict adherence to medical protocols, compliance, and procedural discipline.
Who leads Indrapr.Medical?
Indrapr.Medical is led by Shivakumar Pattabhiraman (Managing Director), a Pragmatic leader with 35 years of experience.
What are Indrapr.Medical's financials?
Indrapr.Medical reported revenue of ₹1K Cr in FY25 with a 5-year revenue CAGR of 14.9%. Operating margin: 16.1%. Market cap: ₹4K Cr.
Culture & Strategy
CultureBureaucratic
InnovationTraditionalist
PaceSteady-Marathon
PurposePurpose-Blended
CustomerPremium-Niche
EmployeeSteady Employer
BrandTrusted
LifecycleMature Stable
Hospital management environment necessitating strict adherence to medical protocols, compliance, and procedural discipline.
Mandate
Needs to drive operational efficiency and capacity utilization in a mature, capital-intensive hospital network.
Needs to drive operational efficiency and capacity utilization in a mature, capital-intensive hospital network.
Financials
Revenue FY25₹1K Cr
PAT FY25₹161 Cr
Rev CAGR 5Y14.9%
OPM16.1%
NPM12.3%
ROE27%
ROCE31.2%
P/E19.2
Fwd P/E17.8
P/B5.3
D/E4.8
Mkt Cap₹4K Cr
Promoter57.9%
Institutional3.2%
Similar Culture
Could You Lead Indrapr.Medical?
Take the Genome Benchmark →